Cargando…
BACE2 distribution in major brain cell types and identification of novel substrates
β-Site APP-cleaving enzyme 1 (BACE1) inhibition is considered one of the most promising therapeutic strategies for Alzheimer’s disease, but current BACE1 inhibitors also block BACE2. As the localization and function of BACE2 in the brain remain unknown, it is difficult to predict whether relevant si...
Autores principales: | Voytyuk, Iryna, Mueller, Stephan A, Herber, Julia, Snellinx, An, Moechars, Dieder, van Loo, Geert, Lichtenthaler, Stefan F, De Strooper, Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238391/ https://www.ncbi.nlm.nih.gov/pubmed/30456346 http://dx.doi.org/10.26508/lsa.201800026 |
Ejemplares similares
-
Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
por: Pigoni, Martina, et al.
Publicado: (2016) -
BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer’s Disease Markers in Elderly Healthy Participants
por: Timmers, Maarten, et al.
Publicado: (2017) -
AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model
por: Marino, Marika, et al.
Publicado: (2022) -
Seizure-6 proteins highlight BACE1 functions in neurobiology
por: Pigoni, Martina, et al.
Publicado: (2016) -
Proteomic Substrate Identification for Membrane Proteases in the Brain
por: Müller, Stephan A., et al.
Publicado: (2016)